The current PE ratio of STAA can't be determined, as the TTM EPS of -$0.41 is negative. The last PE ratio of Staar Surgical, recorded in September 2024, was 84.61.
The PE ratio of Staar Surgical has averaged 232.25 over the last eight years. In the past eight years, STAA's PE ratio was at its highest in the Mar 2018 quarter at 740, when the stock price was $14.8 and the EPS was $0.02. The lowest value was in the Dec 2022 quarter, when it reached 58.48 with a price of $48.54 and an EPS of $0.83.
Maximum annual increase: 467.18% in 2021
Maximum annual decrease: -74.17% in 2021
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | N/A | N/A | $24.21 | -$0.41 |
2023 | 70.93 | 21.29% | $31.21 | $0.44 |
2022 | 58.48 | -62.85% | $48.54 | $0.83 |
2021 | 157.41 | -74.17% | $91.3 | $0.58 |
2021 | 609.38 | 467.18% | $79.22 | $0.13 |
2020 | 107.44 | -58.76% | $34.38 | $0.32 |
2018 | 260.5 | N/A | $31.26 | $0.12 |
2017 | N/A | N/A | $15.5 | -$0.05 |
2016 | N/A | N/A | $10.85 | -$0.3 |
2016 | N/A | N/A | $7.14 | -$0.17 |
2015 | N/A | N/A | $9.03 | -$0.22 |
2014 | 1,610 | N/A | $16.1 | $0.01 |
2012 | N/A | N/A | $5.82 | -$0.05 |
2011 | 262.25 | N/A | $10.49 | $0.04 |
2010 | N/A | N/A | $6.1 | $0 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | N/A | N/A | $24.21 | -$0.41 |
Sep 2024 | 84.61 | -39.58% | $37.23 | $0.44 |
Jun 2024 | 140.03 | 17.05% | $47.61 | $0.34 |
Mar 2024 | 119.63 | 68.66% | $38.28 | $0.32 |
Dec 2023 | 70.93 | -24.09% | $31.21 | $0.44 |
Sep 2023 | 93.44 | -4.02% | $40.18 | $0.43 |
Jun 2023 | 97.35 | 3.52% | $52.57 | $0.54 |
Mar 2023 | 94.04 | 60.81% | $63.95 | $0.68 |
Dec 2022 | 58.48 | -30.37% | $48.54 | $0.83 |
Sep 2022 | 83.99 | -11.58% | $70.55 | $0.84 |
Jul 2022 | 94.99 | -20.92% | $72.19 | $0.76 |
Apr 2022 | 120.12 | -23.69% | $80.48 | $0.67 |
Dec 2021 | 157.41 | -39.64% | $91.3 | $0.58 |
Oct 2021 | 260.8 | -20.71% | $127.79 | $0.49 |
Jul 2021 | 328.93 | -28.47% | $144.73 | $0.44 |
Stock name | PE ratio | Market cap |
---|---|---|
ABT Abbott Laboratories | 17.25 | $229.52B |
NVS Novartis AG | 19.02 | $222.4B |
COO Cooper Companies Inc | 37.45 | $15.65B |
IRIX Iridex Corp | N/A | $15.71M |
STAA Staar Surgical Co | N/A | $835.57M |
The current price to earnings ratio of STAA can't be calculated, as its EPS of -$0.41 is negative.
The 3-year average PE ratio for STAA stock is 93.75.
The 5-year average PE ratio for STAA stock is 195.48.
The highest quarterly PE ratio in the last eight years has been 740 and it was in the Mar 2018 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.